Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements

Colaboración

Año: 2022

Smith-Byrne, K; Cerani, A; Guida, F; Zhou, SR; Agudo, A; Aleksandrova, K; Barricarte, A; Barranco, MR; Bochers, CH; Gram, IT; Han, J; Amos, CI; Hung, RJ; Grankvist, K; Nost, TH; Imaz, L; Chirlaque-Lopez, MD; Johansson, M; Kaaks, R; Kuhn, T; Martin, RM; McKay, JD; Pala, V; Robbins, HA; Sandanger, TM; Schibli, D; Schulze, MB; Travis, RC; Vineis, P; Weiderpass, E; Brennan, P; Johansson, M; Richards, JB

Título: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

• Q3